BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28268233)

  • 1. Does Computed Tomography Still Have Limitations to Distinguish Benign from Malignant Renal Tumors for Radiologists?
    Shin T; Duddalwar VA; Ukimura O; Matsugasumi T; Chen F; Ahmadi N; de Castro Abreu AL; Mimata H; Gill IS
    Urol Int; 2017; 99(2):229-236. PubMed ID: 28268233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of renal cell carcinoma, oncocytoma, and lipid-poor angiomyolipoma by unenhanced, nephrographic, and delayed phase contrast-enhanced computed tomography.
    Ishigami K; Pakalniskis MG; Leite LV; Lee DK; Holanda DG; Rajput M
    Clin Imaging; 2015; 39(1):76-84. PubMed ID: 25457535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiphasic enhancement patterns of small renal masses (≤4 cm) on preoperative computed tomography: utility for distinguishing subtypes of renal cell carcinoma, angiomyolipoma, and oncocytoma.
    Pierorazio PM; Hyams ES; Tsai S; Feng Z; Trock BJ; Mullins JK; Johnson PT; Fishman EK; Allaf ME
    Urology; 2013 Jun; 81(6):1265-71. PubMed ID: 23601445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can radiologists and urologists reliably determine renal mass histology using standard preoperative computed tomography imaging?
    Monn MF; Gellhaus PT; Patel AA; Masterson TA; Tann M; Boris RS
    J Endourol; 2015 Apr; 29(4):391-6. PubMed ID: 25222030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative computer-aided diagnostic algorithm for automated detection of peak lesion attenuation in differentiating clear cell from papillary and chromophobe renal cell carcinoma, oncocytoma, and fat-poor angiomyolipoma on multiphasic multidetector computed tomography.
    Coy H; Young JR; Douek ML; Brown MS; Sayre J; Raman SS
    Abdom Radiol (NY); 2017 Jul; 42(7):1919-1928. PubMed ID: 28280876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small renal masses (≤ 4 cm): differentiation of oncocytoma from renal clear cell carcinoma using ratio of lesion to cortex attenuation and aorta-lesion attenuation difference (ALAD) on contrast-enhanced CT.
    Gentili F; Bronico I; Maestroni U; Ziglioli F; Silini EM; Buti S; de Filippo M
    Radiol Med; 2020 Dec; 125(12):1280-1287. PubMed ID: 32385827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subtype Differentiation of Small (≤ 4 cm) Solid Renal Mass Using Volumetric Histogram Analysis of DWI at 3-T MRI.
    Li A; Xing W; Li H; Hu Y; Hu D; Li Z; Kamel IR
    AJR Am J Roentgenol; 2018 Sep; 211(3):614-623. PubMed ID: 29812980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective Evaluation of (99m)Tc-sestamibi SPECT/CT for the Diagnosis of Renal Oncocytomas and Hybrid Oncocytic/Chromophobe Tumors.
    Gorin MA; Rowe SP; Baras AS; Solnes LB; Ball MW; Pierorazio PM; Pavlovich CP; Epstein JI; Javadi MS; Allaf ME
    Eur Urol; 2016 Mar; 69(3):413-6. PubMed ID: 26386607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small (< or = 4 cm) cortical renal tumors: characterization with multidetector CT.
    Alshumrani G; O'Malley M; Ghai S; Metser U; Kachura J; Finelli A; Mattar K; Panzarella T
    Abdom Imaging; 2010 Aug; 35(4):488-93. PubMed ID: 19536589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of benign from malignant solid renal lesions using CT-based radiomics and machine learning: comparison with radiologist interpretation.
    Wentland AL; Yamashita R; Kino A; Pandit P; Shen L; Brooke Jeffrey R; Rubin D; Kamaya A
    Abdom Radiol (NY); 2023 Feb; 48(2):642-648. PubMed ID: 36370180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated classification of solid renal masses on contrast-enhanced computed tomography images using convolutional neural network with decision fusion.
    Zabihollahy F; Schieda N; Krishna S; Ukwatta E
    Eur Radiol; 2020 Sep; 30(9):5183-5190. PubMed ID: 32350661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aorta-Lesion-Attenuation-Difference (ALAD) on contrast-enhanced CT: a potential imaging biomarker for differentiating malignant from benign oncocytic neoplasms.
    Dhyani M; Grajo JR; Rodriguez D; Chen Z; Feldman A; Tambouret R; Gervais DA; Arellano RS; Hahn PF; Samir AE
    Abdom Radiol (NY); 2017 Jun; 42(6):1734-1743. PubMed ID: 28197683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can contrast-enhanced ultrasound and acoustic radiation force impulse imaging characterize CT-indeterminate renal masses? A prospective evaluation with histological confirmation.
    Thaiss WM; Bedke J; Kruck S; Spira D; Stenzl A; Nikolaou K; Horger M; Kaufmann S
    World J Urol; 2019 Jul; 37(7):1339-1346. PubMed ID: 30324296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of Predominantly Solid Enhancing Lipid-Poor Renal Cell Masses by Use of Contrast-Enhanced CT: Evaluating the Role of Texture in Tumor Subtyping.
    Varghese BA; Chen F; Hwang DH; Cen SY; Desai B; Gill IS; Duddalwar VA
    AJR Am J Roentgenol; 2018 Dec; 211(6):W288-W296. PubMed ID: 30240299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An In-vivo Prospective Study of the Diagnostic Yield and Accuracy of Optical Biopsy Compared with Conventional Renal Mass Biopsy for the Diagnosis of Renal Cell Carcinoma: The Interim Analysis.
    Buijs M; Wagstaff PGK; de Bruin DM; Zondervan PJ; Savci-Heijink CD; van Delden OM; van Leeuwen TG; van Moorselaar RJA; de la Rosette JJMCH; Laguna Pes MP
    Eur Urol Focus; 2018 Dec; 4(6):978-985. PubMed ID: 29079496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative Contour Analysis as an Image-based Discriminator Between Benign and Malignant Renal Tumors.
    Yap FY; Hwang DH; Cen SY; Varghese BA; Desai B; Quinn BD; Gupta MN; Rajarubendra N; Desai MM; Aron M; Liang G; Aron M; Gill IS; Duddalwar VA
    Urology; 2018 Apr; 114():121-127. PubMed ID: 29305199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement patterns of renal masses during multiphase helical CT acquisitions.
    Garant M; Bonaldi VM; Taourel P; Pinsky MF; Bret PM
    Abdom Imaging; 1998; 23(4):431-6. PubMed ID: 9663282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment differentiation of renal cell carcinoma subtypes by CT: the influence of different tumor enhancement measurement approaches.
    Zokalj I; Marotti M; Kolarić B
    Int Urol Nephrol; 2014 Jun; 46(6):1089-100. PubMed ID: 24381132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential diagnosis of renal oncocytoma and chromophobe renal cell carcinoma using CT features: a central scar-matched retrospective study.
    Li X; Nie P; Zhang J; Hou F; Ma Q; Cui J
    Acta Radiol; 2022 Feb; 63(2):253-260. PubMed ID: 33497276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative differentiation of minimal-fat angiomyolipomas from renal cell carcinomas using grating-based x-ray phase-contrast computed tomography: An ex vivo study.
    Birnbacher L; Braunagel M; Willner M; Marschner M; De Marco F; Viermetz M; Auweter S; Notohamiprodjo S; Hellbach K; Notohamiprodjo M; Staehler M; Pfeiffer D; Reiser MF; Pfeiffer F; Herzen J
    PLoS One; 2023; 18(4):e0279323. PubMed ID: 37058505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.